Related Experiment Video
Updated: Jul 28, 2026
10:44
Single Cell Multiplex Reverse Transcription Polymerase Chain Reaction After Patch-clamp
Published on: June 20, 2018
A polymorphic marker for the human cathepsin B gene.
J R MacKenzie1, S L Mason, J G Hickford
1Department of Biochemistry and Molecular Biology, the John Curtin School of Medical Research, Australian National University, Canberra, Australia. jason.mackenzie@anu.edu.au
Molecular and Cellular Probes
|August 22, 2001
Summary
Researchers identified a new genetic marker for human cathepsin B (CTSB), a protein linked to cancer spread. This marker, based on variations in intron 7, can aid in future cancer research and genetic studies.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Human cathepsin B (CTSB) is a key enzyme involved in tumor invasion and metastasis.
- Genetic variations can influence protein function and disease susceptibility.
Purpose of the Study:
- To develop and characterize a polymorphic marker for the human CTSB gene.
- To assess the utility of this marker in genetic studies, particularly for cancer research.
Main Methods:
- Polymerase Chain Reaction (PCR)-based amplification of a specific region in CTSB intron 7.
- Analysis of amplicon length differences to identify distinct alleles.
- Sequencing to confirm nucleotide variations.
- Genotyping of a cohort of Australian blood donors to determine allele frequencies and heterozygosity.
Main Results:
- A PCR-based polymorphic marker was developed for human CTSB, located in intron 7 near the exon 8 splice acceptor site.
- Two alleles, designated A and B, were identified based on a 19-nucleotide difference in amplicon length.
- Allele frequencies in the study cohort were 0.614 for A and 0.386 for B, with an observed heterozygosity of 0.457.
- Sequencing revealed an additional nucleotide difference between alleles.
Conclusions:
- The described polymorphic marker for human CTSB provides a valuable tool for genetic research.
- These CTSB alleles can potentially serve as markers in linkage and association studies for cancers and other diseases.
